Comparing the Prognosis of Patients With Cardia and Non-cardia Gastric Cancer.
Comparing the Stage-for-Stage Prognosis of Patients With Cardia and Non-cardia Gastric Cancer After Operation.
1 other identifier
observational
1,000
1 country
3
Brief Summary
To comparing the stage-for-stage prognosis of patients with cardia and non-cardia gastric cancer after operation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2019
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 28, 2019
CompletedFirst Posted
Study publicly available on registry
March 29, 2019
CompletedStudy Start
First participant enrolled
July 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJuly 5, 2019
March 1, 2019
4.5 years
March 28, 2019
July 2, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Disease Free Survival（DFS）
The time from the primary operation to disease recurrence or death.
5 years
Secondary Outcomes (1)
Overall survival(OS)
5 years
Study Arms (2)
Cardia gastric cancer
Cardiac gastric cancer is defined as a cancer center lies arising 2-5 cm from the gastric mucosa distal to the esophagogastric junction.
Non-cardia gastric cancer
Non-cardia gastric cancer is defined as tumors originated from the gastric mucosa distal to the cardia.
Interventions
We classify gastric cancer into cardia gastric cancer and non-cardia gastric cancer.
Eligibility Criteria
gastric cancer
You may qualify if:
- Histopathology or cytopathology proven cardia or non-cardia gastric cancer;
- Operable gastric cancer patients: primary lesions can be completely excision, no distant metastasis;
- Life expectancy of at least 6 months;
- ECOG（Eastern Cooperative Oncology Group ） score 0-1;
- Age: 18\~80 years old;
- Normal hemodynamic indices before the recruitment (including blood cell count and liver/kidney function).
- For example: WBC（White blood cell count ）\>4.0×109/L; NEU（Neutrophils）\>1.5×109/L; PLT（Platelet）\>100×109/L;
- Roughly normal cardiopulmonary function: No coronary heart disease, myocardial infarction, pulmonary heart disease, refractory hypertension;
- Not concomitant with other uncontrollable benign diseases before the recruitment;
- Voluntarily signed the informed consent.
You may not qualify if:
- Advanced gastric cancer patients with distant metastasis and inoperable ;
- Pregnant or lactating women;
- Patients who have no desire to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Affiliated Hospital of Qinghai Universitylead
- Qinghai People's Hospitalcollaborator
- LanZhou Universitycollaborator
Study Sites (3)
The Second Hospital of Lanzhou University
Lanzhou, Gansu, China
Affiliated Hospital of Qinghai University
Xining, Qinghai, 810000, China
People's Hospital of Qinghai Province
Xining, Qinghai, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 28, 2019
First Posted
March 29, 2019
Study Start
July 8, 2019
Primary Completion
December 31, 2023
Study Completion
December 31, 2024
Last Updated
July 5, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share